3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform.

Media coverage

• Title	3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform.
  Media name/outlet	Cision Nordic Companies Press Releases (Scandinavia)
  Country/Territory	Denmark
  Date	20/06/22
  Persons	Karl Ægir Karlsson

• Title	3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform.
  Media name/outlet	Cision News
  Country/Territory	Sweden
  Date	20/06/22
  URL	ct.moreover.com/?a=48034014100&p=1gw&v=1&x=BQc9CkH417Sa5dUSZGRzgw
  Persons	Karl Ægir Karlsson